Form 4: Metagenomi CFO Pamela Wapnick Reports Acquisition of Stock Options and Restricted Stock Units

Pamela Wapnick, CFO of Metagenomi, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in the company.

Summary

• Pamela Wapnick, the Chief Financial Officer of Metagenomi, Inc. (MGX), filed a Form 4 on April 3, 2025, reporting changes in beneficial ownership.
• On April 1, 2025, Wapnick acquired 14,000 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs vest with 25% vesting on June 5, 2026, and the remainder vesting in 12 equal quarterly installments, contingent upon continued service with the company.
• Also on April 1, 2025, Wapnick acquired options to buy 84,000 shares of common stock at an exercise price of $1.32.
• These options vest with 25% vesting on April 1, 2026, and the remainder vesting in 36 equal monthly installments, contingent upon continued service with the company.
• Following these transactions, Wapnick directly owns 73,684 shares of common stock and holds options for 84,000 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock and option grants to a key executive. The vesting schedules suggest a long-term commitment.

Positives

• The acquisition of stock options and RSUs by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The vesting schedules for the RSUs and stock options incentivize the CFO to remain with the company, which could benefit shareholders.

Key Dates

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, CFO, Pamela Wapnick, Metagenomi, MGX